BPA Call W81K0020A0014-W81K0024F0147
Award Date
10/1/24
Potential Completion Date
9/30/25
Potential Value
$75K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Pharmalucence, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
El Paso, TX 79918, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Pharmalucence, Inc. for the supply of radiopharmaceuticals and related products. The contract has a ceiling value of $75,000.00 and a period of performance through September 30, 2024. Pharmalucence, Inc. is a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The DHA, a component of the Department of...
This is a firm fixed-price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc. for the supply of various radiopharmaceuticals. The $100,000.00 contract has an ultimate completion date of September 30, 2025 and does not have a set-aside designation. Pharmalucence, Inc. is a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and...
This federal contract award, valued at $250,000.00, was issued by the Defense Health Agency (DHA) to Lantheus Medical Imaging, Inc., a for-profit manufacturer of diagnostic medical imaging agents and radiopharmaceutical products. The contract covers the provision of various radiopharmaceuticals, with a period of performance through September 30, 2024. This award is part of a larger Blanket Purchase Agreement (BPA) that Lantheus Medical Imaging holds with the DHA, valued at $6.5 million and...
This is a federal contract award to Medi-Physics, Inc., a subsidiary of General Electric Company operating as GE Healthcare, for the provision of radiopharmaceuticals and supplies to the Defense Health Agency (DHA). The contract, with a ceiling value of $150,000.00, is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type. The award has an ultimate completion date of September 30, 2025. Medi-Physics, a large, for-profit manufacturing company, is a prominent supplier of...
This is a $375,785.71 fixed-price with economic price adjustment purchase order contract awarded to Lantheus Medical Imaging, Inc. by the Defense Health Agency (DHA) for the procurement of radiopharmaceutical diagnostic products. The contract is set aside for small businesses and has an ultimate completion date of December 31, 2014. Lantheus Medical Imaging, a for-profit manufacturer of diagnostic medical imaging agents and products, is the prime contractor. The contract is part of a larger...
This federal contract award is for the provision of various radiopharmaceuticals to the Defense Health Agency (DHA) and U.S. Army Medical Command. The prime contractor is Curium US LLC, a foreign-owned, for-profit manufacturer of nuclear medicine products. The contract was awarded on October 1, 2023 as a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type and a total ceiling value of $100,000.00. It has an ultimate completion date of September 30, 2024. The contract...
This firm fixed price Blanket Purchase Agreement (BPA) call award from the Defense Health Agency is for 123 DATSCAN services to diagnose imaging agents and radio-pharmaceuticals that can help with a Parkinsonian syndrome diagnosis. The contract has a potential value of $0.00 and performance will occur in Bethesda, Maryland. Medi-Physics, Inc. is the prime contractor selected to deliver the requested diagnosing services under this BPA call contract awarded on February 7, 2019 and completing on...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceuticals to the Defense Health Agency (DHA). The contract, which has a ceiling value of $19,596.65, is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type and a performance period through September 30, 2024. Cardinal Health 414 is a leading provider of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to various...
This federal contract award is for the provision of radiopharmaceuticals and supplies by Curium US LLC, a foreign-owned, for-profit manufacturer, to the Defense Health Agency (DHA) and the U.S. Army Medical Command. The contract, with a ceiling value of $200,000.00, is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type, awarded on October 1, 2023. The contract supports the agency's healthcare operations for over 9.4 million beneficiaries, with deliveries of...
This is a Firm Fixed Price contract awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to TDS Med, Inc., a small disadvantaged business, to provide pharmaceutical products. The contract has a ceiling value of $300,000.00 and runs from October 1, 2014 to September 30, 2015. It is a call order under a Blanket Purchase Agreement (BPA) awarded by the Defense Health Agency in September 2019 to provide pharmaceutical products and supplies, including shortage...